beta-Endorphin-induced hyperthermia in the cat.

Review Approach involved administering the peptide directly into the third cerebral ventricle of conscious, unrestrained feline subjects. Investigators monitored thermal shifts following the delivery of fifty micrograms of the test substance. A subsequent intervention utilized twenty to one hundred micrograms of an antagonist to evaluate inhibitory effects. Researchers performed these trials at three specific ambient settings: four, twenty-two, and thirty-four degrees Celsius. The team tracked core temperature fluctuations to quantify the magnitude of the induced physiological change. This systematic evaluation allowed for the comparison of responses across different external heat loads. The experimental protocol focused on isolating the central nervous system's reaction to opioid stimulation. Data collection prioritized the timing of antagonist delivery to confirm receptor-mediated activity.

Key Findings From the Literature indicate that the peptide consistently elevates core body temperature in feline subjects. A dose of forty micrograms produces a measurable increase in thermal levels across all tested environments. The magnitude of this temperature rise correlates positively with the warmth of the surrounding air. Specifically, the hyperthermic response is most pronounced when the ambient environment reaches thirty-four degrees Celsius. Administration of twenty to one hundred micrograms of the antagonist effectively reduces the peptide-induced thermal elevation. This inhibitory effect occurs when the drug is delivered one hour after the initial peptide injection. The data suggest that the observed physiological changes are mediated by a central, naloxone-sensitive receptor. These results highlight a consistent pattern of thermal modulation driven by opioid signaling pathways.

The authors propose that beta-endorphin triggers a rise in feline body temperature via central pathways. This thermal elevation appears mediated by specific receptors sensitive to naloxone inhibition. Evidence suggests these receptors likely correspond to the v2 subtype. Activation of these sites produces consistent physiological shifts across diverse thermal environments. The researchers observe that environmental warmth amplifies the magnitude of the peptide-induced heat response. These findings align with observations from studies using D-Ala2-Met-enkephalinamide as a stimulant. The data support a model where opioid signaling pathways regulate internal heat production. Such mechanisms demonstrate how internal chemistry interacts with external climate to maintain homeostasis.